SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-284734
Filing Date
2022-11-14
Accepted
2022-11-14 16:49:05
Documents
14
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d418509d8k.htm   iXBRL 8-K 26153
2 EX-99.1 d418509dex991.htm EX-99.1 67349
6 GRAPHIC g418509g1114220821746.jpg GRAPHIC 4234
  Complete submission text file 0001193125-22-284734.txt   232875

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20221114.xsd EX-101.SCH 2868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20221114_lab.xml EX-101.LAB 17997
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20221114_pre.xml EX-101.PRE 11270
8 EXTRACTED XBRL INSTANCE DOCUMENT d418509d8k_htm.xml XML 3438
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36577 | Film No.: 221386935
SIC: 2834 Pharmaceutical Preparations